Monitoring and management of the patient with stargardt disease

Stargardt disease (STGD1) represents one of the major common causes of inherited irreversible visual loss. Due to its high phenotypic and genotypic heterogeneity, STGD1 is a complex disease to understand. Non-invasive imaging, biochemical, and genetic advances have led to substantial improvements in unveiling the disease processes and novel promising therapeutic landscapes have been proposed. This review recapitulates the mod-alities for monitoring patients with STGD1 and the therapeutic options currently under investigation for the different stages of the disease.